Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYTheratechnologies’ Oncology Platform Improves Efficacy and Tolerability of Docetaxel in Vivo and in VitroPREV STORYCHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma